A Pfizer-BioNTech trial found the vaccine extremely effective in 12- to 15-year-olds, with no coronavirus infections among children who received it.
Wednesday, March 31, 2021 6:46 AM EST
The findings, if they hold up, may speed a return to normalcy for millions of American families.
Depending on regulatory approval,...